Picture of Corline Biomedical AB logo

CLBIO — Corline Biomedical AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Brief: Corline Biomedical Completes Directed Issue Of About SEK 35.5 Million

March 30 (Reuters) - Corline Biomedical AB CLBIO.ST>:
    * SAID ON MONDAY HAD COMPLETED A DIRECTED ISSUE OF ABOUT SEK
35.5
MILLION
    * COMPLETED A DIRECTED CASH ISSUE OF 3,300,000 ORDINARY
SHARES AT
A SUBSCRIPTION PRICE OF SEK 10.75 PER SHARE
    * THE ISSUE WAS SUBSCRIBED FOR BY SWEDISH INSTITUTIONAL
INVESTORS,
INCLUDING M2 ASSET MANAGEMENT, AND THE EXISTING SHAREHOLDER
HEALTHINVEST PARTNERS

    
    
 Source text for Eikon:  urn:newsml:reuters.com:*:nGNEbt9HN
    
 Further company coverage:  CLBIO.ST  
   


 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00))

Recent news on Corline Biomedical AB

See all news